Conversations With Patients About Mild/Moderate Multiple Sclerosis

News
Video

The expert panel examines early multiple sclerosis (MS) and patients with mild MS even in later stages of the disease, emphasizing crucial information to convey to patients throughout their journey; faculty also explore cases where disease-modifying therapies (DMTs) may not be utilized.

  1. What is important for physicians to share with different types of patients and with patients at different junctures of their MS journey?
  2. Are there any patients with mild disease who won’t be treated with DMTs?
Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.